Logo

American Heart Association

  106
  0


Final ID:

Bisecting the Future of HFpEF Therapy: Medical and Procedural Therapy

  • Redfield, Margaret  ( Mayo Clinic-Dr. Margaret Redfield , Rochester , Minnesota , United States )
  • Reza, Nosheen  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Margaret Redfield: DO NOT have relevant financial relationships | Nosheen Reza: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Speaker:Zoll:Past (completed) ; Advisor:American Regent:Past (completed) ; Advisor:Roche Diagnostics:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Getting Closer to the Summit: New HFpEF Treatments

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Finerenone and Risk of Hyperkalemia in Patients with Heart failure with Mildly Reduced or Preserved Ejection Fraction

Vardeny Orly, Zannad Faiez, Pitt Bertram, Lay-flurrie James, Viswanathan Prabhakar, Horvat-broecker Andrea, Scalise Andrea, Mcmurray John, Solomon Scott, Vaduganathan Muthiah, Claggett Brian, Desai Akshay, Jhund Pardeep, Lam Carolyn, Senni Michele, Shah Sanjiv, Voors Adriaan

Effects of Tirzepatide on Cardiorenal End-Organ Damage in Heart Failure and Preserved Ejection Fraction: Insights from the SUMMIT trial

Borlaug Barry

More abstracts from these authors:
There's More to the Heart than the Right Ventricle: Focus on Left Ventricular Function in PAH

Horn Evelyn, Redfield Margaret, De Man Frances

PH in HFpEF: A Rapidly Increasing Demographic

Sarma Satyam, Reddy Yogesh, Redfield Margaret

You have to be authorized to contact abstract author. Please, Login
Not Available